ロード中...
A triple-blinded, randomized, placebo-controlled trial to examine the efficacy of buspirone added to typical antipsychotic drugs in patients with chronic schizophrenia
BACKGROUND: The purpose of this study was to test the hypothesis that the addition of buspirone, a partial agonist of 5HT1A receptor, to ongoing treatment with typical antipsychotics would improve the positive and negative symptoms in patients with chronic schizophrenia. MATERIALS AND METHODS: In th...
保存先:
| 出版年: | J Res Med Sci |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Medknow Publications & Media Pvt Ltd
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4400707/ https://ncbi.nlm.nih.gov/pubmed/25983765 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|